Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University Hospital, Essen | OTHER |
Not provided
Not provided
Not provided
Not provided
The induction of anaesthesia is one of the most critical situations for high-risk-patients undergoing interventions surgery. For several reasons, it is crucial to maintain adequate blood pressure and cardiac output during this phase.
This retrospective cohort study aims to find out if the choice of the induction agent has a major impact on blood pressure and the use of catecholamines during the induction and the interventional procedure in patients undergoing interventional mitral valve repair.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Etomidate group | Patients who received etomidate for induction of anaesthesia during interventional mitral valve repair (Mitraclip) |
| |
| Sevoflurane group | Patients who received sevoflurane for induction of anaesthesia during interventional mitral valve repair (Mitraclip) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Etomidate | Drug | Use of etomidate |
| |
| Sevoflurane |
| Measure | Description | Time Frame |
|---|---|---|
| Post-induction hypotension | Hypotension in the first 20 minutes after induction of anesthesia | First 20 minutes after induction of anaesthesia |
| Measure | Description | Time Frame |
|---|---|---|
| Use of catecholamines after induction during the first 20 minutes after inductionafter induction | Use of catecholamines during the first 20 minutes after induction of anaesthesia | First 20 minutes after induction |
| Use of catecholamines |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patients undergoing interventional mitral valve repair
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Adrian E Stephan, MD | Heidelberg University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Anästhesiologische Klinik (Universitätsklinikum Heidelberg) | Heidelberg | Baden-Würtemberg | 69120 | Germany |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007022 | Hypotension |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D005045 | Etomidate |
| D000077149 | Sevoflurane |
| ID | Term |
|---|---|
| D007093 | Imidazoles |
| D001393 | Azoles |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
| Drug |
Use of sevoflurane |
|
Use of catecholamines during the procedure
| Length of procedure (Approximately 60 to 90 minutes in average) |
| D008738 |
| Methyl Ethers |
| D004987 | Ethers |
| D009930 | Organic Chemicals |
| D006845 | Hydrocarbons, Fluorinated |
| D006846 | Hydrocarbons, Halogenated |
| D006838 | Hydrocarbons |